China Resources Pharmaceutical Group Future Growth
Future criteria checks 2/6
China Resources Pharmaceutical Group is forecast to grow earnings and revenue by 13.4% and 10.1% per annum respectively. EPS is expected to grow by 12.3% per annum. Return on equity is forecast to be 9.6% in 3 years.
Key information
13.4%
Earnings growth rate
12.3%
EPS growth rate
Pharmaceuticals earnings growth | 23.7% |
Revenue growth rate | 10.1% |
Future return on equity | 9.6% |
Analyst coverage | Good |
Last updated | 22 Jan 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 344,012 | 5,859 | 8,434 | 10,160 | 6 |
12/31/2024 | 311,622 | 5,276 | 7,495 | 10,542 | 7 |
12/31/2023 | 282,659 | 4,635 | 7,278 | 6,531 | 8 |
6/30/2023 | 267,330 | 4,160 | 8,467 | 11,587 | N/A |
3/31/2023 | 260,718 | 4,154 | 8,899 | 12,109 | N/A |
12/31/2022 | 254,106 | 4,147 | 9,330 | 12,631 | N/A |
9/30/2022 | 251,071 | 4,252 | 8,319 | 11,789 | N/A |
6/30/2022 | 248,035 | 4,356 | 7,308 | 10,947 | N/A |
3/31/2022 | 242,421 | 4,062 | 8,567 | 11,895 | N/A |
12/31/2021 | 236,806 | 3,769 | 9,826 | 12,843 | N/A |
9/30/2021 | 231,165 | 3,463 | 7,193 | 9,845 | N/A |
6/30/2021 | 225,523 | 3,158 | 4,560 | 6,847 | N/A |
3/31/2021 | 212,973 | 3,228 | 5,364 | 7,527 | N/A |
12/31/2020 | 200,423 | 3,297 | 6,169 | 8,206 | N/A |
9/30/2020 | 196,171 | 3,063 | 7,973 | 9,926 | N/A |
6/30/2020 | 191,918 | 2,828 | 9,778 | 11,645 | N/A |
3/31/2020 | 198,186 | 3,057 | 7,960 | 9,893 | N/A |
12/31/2019 | 204,454 | 3,286 | 6,142 | 8,141 | N/A |
9/30/2019 | 201,163 | 4,025 | 6,205 | 8,122 | N/A |
6/30/2019 | 197,871 | 4,763 | 6,268 | 8,104 | N/A |
3/31/2019 | 193,780 | 4,370 | 6,281 | 8,175 | N/A |
12/31/2018 | 189,689 | 3,978 | 6,293 | 8,247 | N/A |
9/30/2018 | 186,612 | 3,950 | 5,681 | 7,316 | N/A |
6/30/2018 | 183,535 | 3,922 | 5,068 | 6,385 | N/A |
3/31/2018 | 178,034 | 3,703 | 4,087 | 5,621 | N/A |
12/31/2017 | 172,532 | 3,483 | 3,105 | 4,858 | N/A |
9/30/2017 | 168,180 | 3,239 | -395 | 1,744 | N/A |
6/30/2017 | 163,827 | 2,996 | -3,894 | -1,369 | N/A |
3/31/2017 | 160,266 | 2,909 | N/A | 1,375 | N/A |
12/31/2016 | 156,705 | 2,821 | N/A | 4,120 | N/A |
9/30/2016 | 153,813 | 2,513 | N/A | 5,107 | N/A |
6/30/2016 | 150,921 | 2,204 | N/A | 6,095 | N/A |
3/31/2016 | 148,744 | 2,527 | N/A | 6,042 | N/A |
12/31/2015 | 146,568 | 2,850 | N/A | 5,989 | N/A |
12/31/2014 | 135,749 | 2,646 | N/A | 4,187 | N/A |
12/31/2013 | 116,951 | 2,640 | N/A | 4,102 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CRPG.F's forecast earnings growth (13.4% per year) is above the savings rate (2.2%).
Earnings vs Market: CRPG.F's earnings (13.4% per year) are forecast to grow slower than the US market (15.5% per year).
High Growth Earnings: CRPG.F's earnings are forecast to grow, but not significantly.
Revenue vs Market: CRPG.F's revenue (10.1% per year) is forecast to grow faster than the US market (8.1% per year).
High Growth Revenue: CRPG.F's revenue (10.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CRPG.F's Return on Equity is forecast to be low in 3 years time (9.6%).